Methotrexate gel with or without electric current for vitiligo
Part of Skin clinical trials.
This study compares two ways of applying a medicine called methotrexate to vitiligo patches: one uses a special gel, and the other uses a mild electric current to help the medicine go deeper into the skin. The goal is to see which method helps restore skin color better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- Your vitiligo has been stable for at least 6 months (no new or spreading patches).
- You have vitiligo on a limited area, suitable for a cream or gel treatment.
- You have not used methotrexate (oral or cream) in the past 3 months.
- You are willing to avoid other vitiligo treatments during the study.
- You are not pregnant or breastfeeding, and have no metal implants or pacemaker.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to treat vitiligo by combining a topical cream (methotrexate) with a special laser treatment (fractional CO2 laser) on similar patches on both sides of the body. It aims to see if this combination helps repigment the skin better.
This trial tests a new treatment for non-segmental vitiligo that uses a special liquid made from stem cells, applied through tiny needle pricks or small injections, alongside standard light therapy. It may help restore pigment to white patches with fewer side effects than traditional treatments.
This study tests whether a methotrexate lotion or minoxidil lotion is better at regrowing hair in people with patchy hair loss on the scalp. You will use one of the treatments for a period of time, and the doctors will check your progress.
This trial tests whether adding a daily nasal spray (Melanotan II) to light therapy helps restore color in stable vitiligo patches. It may be a good option for adults with mild to moderate nonsegmental vitiligo that hasn't changed in at least 6 months.
This trial tests a new medicine called TEV-53408 to see if it can help with vitiligo, a condition that causes white patches on the skin. It may help by restoring skin color, and the study will check how safe and effective it is.
This study tests whether combining hyperbaric oxygen (breathing pure oxygen in a special chamber) with narrowband UVB light therapy can improve vitiligo, a condition that causes white patches on the skin. The treatment aims to restore skin color by helping skin cells produce pigment.
Hear when a new Vitiligo - Evaluation of Methotrexate Iontophoresis and Topical Methotrexate Gel as Localized Treatment Approache trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.